← back to search

Anhar Hassan

University College Dublin · IE
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, and Botulinum Toxin and Related Neurological Disorders.
h-index
35
citations
3,626
works
138
NIH funding
primary concept
email

Recent publications

Nitrous oxide abuse: single centre experience of nitrous oxide induced myeloneuropathy.
2026cited by 0position: contributordoi
Correction: Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.
2025cited by 0position: contributordoi
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.
2023cited by 25position: contributordoi
Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.
2023cited by 15position: contributordoi
Deep Brain Stimulator Device Infection: The Mayo Clinic Rochester Experience.
2023cited by 14position: contributordoi
Outpatient Motor Retraining for Functional Movement Disorder: Predictors of a Favorable Short-Term Response.
2023cited by 5position: contributordoi
Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases.
2022cited by 84position: contributordoi
The clinical and electrophysiological investigation of tremor
Clinical Neurophysiology 2022cited by 82position: middledoi
The clinical and electrophysiological investigation of tremor.
2022cited by 64position: contributordoi
Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C.
2022cited by 48position: contributordoi
The Effects of Deep Brain Stimulation in Patients with Multiple System Atrophy.
2022cited by 11position: contributordoi
Effectiveness of Thalamic Ventralis Oralis Anterior and Posterior Nuclei Deep Brain Stimulation for Posttraumatic Dystonia.
2022cited by 6position: contributordoi
Utility of routine surface electrophysiology to screen for functional tremor prior to surgical treatment of essential tremor.
2022cited by 5position: contributordoi
Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis?
2022cited by 3position: contributordoi
Speech-induced action myoclonus.
2022cited by 2position: contributordoi
Natural History of "Pure" Primary Lateral Sclerosis.
2021cited by 16position: contributordoi
Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy.
2021cited by 12position: contributordoi
Clinical Characteristics of Patients with Gait Instability after MR-Guided Focused Ultrasound Thalamotomy.
2021cited by 10position: contributordoi
Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility.
2021cited by 10position: contributordoi
Utility of tremor electrophysiology studies.
2021cited by 10position: contributordoi
A prospective pilot study of the effects of deep brain stimulation on olfaction and constipation in Parkinson's disease.
2021cited by 8position: contributordoi
Holmes Tremor With Perirolandic Demyelinating Lesions: A Distinct Clinicoradiographic Syndrome.
2021cited by 4position: contributordoi
Deep Brain Stimulation and Treatment Outcomes of Young- and Late-Onset (≤55 Years) Parkinson's Disease: A Population-Based Study.
2021cited by 3position: contributordoi
An Undifferentiated Spell: The Answer is in The Pillbox.
2021cited by 0position: contributordoi
Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic.
2020cited by 70position: contributordoi
Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future.
2020cited by 31position: contributordoi
Ataxia and tolerance after thalamic deep brain stimulation for essential tremor.
2020cited by 23position: contributordoi
False-positive anti-neuronal nuclear antibody type 1 in a patient with RFC1 repeat expansion: Preventing "phenotype creep" in autoimmune neurology.
2020cited by 14position: contributordoi
Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10).
2020cited by 9position: contributordoi
Deep brain stimulation for orthostatic tremor: A single-center case series.
2020cited by 8position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Zoltán Mari · Cleveland Clinic3 papers (2014–2018)Günther Deuschl · John Wiley & Sons (United States)3 papers (2017–2022)Mark Guttman · University of Toronto3 papers (2014–2018) · 3 papers (2014–2018)Bastiaan R. Bloem · University of Lausanne2 papers (2014–2018)Michael S. Okun · Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases2 papers (2013–2017)E. Ray Dorsey · Global Brain Health Institute2 papers (2014–2018)Caroline M. Tanner · San Francisco VA Medical Center2 papers (2014–2018)Hugo Botha · Maine Farmland Trust2 papers (2019–2019)William T. Hu · Johnson University2 papers (2021–2022)Christopher G. Goetz · Rush University Medical Center2 papers (2014–2018)Jon Stone · MRC Centre for Regenerative Medicine1 papers (2022–2022)Andrew P. Duker · University of Toledo1 papers (2017–2017)Kevin Biglan · Eli Lilly (United States)1 papers (2014–2014)Jens Volkmann · Medizinische Hochschule Hannover1 papers (2017–2017) · 1 papers (2018–2018)Jorge Guridi · Navarre Institute of Health Research1 papers (2017–2017)Alberto J. Espay · University of Cincinnati1 papers (2017–2017)Alexander Pantelyat · Johns Hopkins University1 papers (2018–2018) · 1 papers (2018–2018)